Appetite for initial public offerings may not be particularly healthy, but that has not stopped JPMorgan testing investor interest in a float of medical device company Kai Medical.

The IPO is thought to be worth up to $100 million. The company claims its methods for treating sleep apnea are quieter and easier to maintain than the masks used by incumbent market leader ResMed .